Filing Details
- Accession Number:
- 0001567619-19-009025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-22 17:58:34
- Reporting Period:
- 2019-04-18
- Accepted Time:
- 2019-04-22 17:58:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1348911 | Kalvista Pharmaceuticals Inc. | KALV | Pharmaceutical Preparations (2834) | 200915291 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1366244 | L Benjamin Palleiko | C/O Kalvista Pharmaceuticals, Inc. 55 Cambridge Parkway, Suite 901E Cambridge MA 02142 | Cbo, Cfo And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-04-18 | 1,073 | $6.74 | 33,573 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-04-18 | 1,073 | $25.51 | 32,500 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-04-22 | 2,000 | $8.39 | 34,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-04-22 | 2,000 | $25.80 | 32,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-04-18 | 1,073 | $0.00 | 1,073 | $6.74 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-04-22 | 2,000 | $0.00 | 2,000 | $8.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 59,611 | 2026-12-28 | No | 4 | M | Direct | |
| 47,354 | 2026-11-21 | No | 4 | M | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.50 to $25.565 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option vests over a 4 year period: 25% on August 26, 2017 after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.80 to $25.805 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option vests over a 4 year period: 25% on August 26, 2017, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.
Billionaire Hedge Funds
